Viatris Acquires Pacira Biosciences for $1.65 Billion Deal
Deals·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Viatris pledged Thursday to buy small biotech company Pacira Biosciences for $1.65 billion, sending Pacira stock skyrocketing.
The deal hands Viatris two non-opioid pain treatments that enhance its pain drug portfolio.
ViatrisPacira Biosciences
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Viatris pledged Thursday to buy small biotech company Pacira Biosciences for $1.65 billion, sending Pacira stock skyrocketing.”
IBD — Pacira Biosciences Snags $1.65 Billion Viatris Takeover Deal; Shares Fly“<figure><div><img”
biopharma dive — Viatris boosts pain drug portfolio with $1.7B buyout of Pacira